Roche purchased the New York City-based startup for $1.9 billion on a “fully diluted basis, subject to certain adjustments,” according to an April 6 statement.
Under the agreement, Flatiron Health will continue its operations as a separate legal entity. Flatiron Health, founded by two former Google employees and backed by Google’s parent company Alphabet, analyzes data it collects from its oncology-specific EHR to improve cancer treatments.
Roche announced its intent to acquire Flatiron Health in February. At the time, Roche already had a 12.6 percent stake in the healthcare startup.
The acquisition will advance both companies’ focus on data-driven personalized oncology care, according to Roche officials.
More articles on health IT:
English hospital deploys Epic EHR alert to identify sepsis: 3 things to know
Startup Insider: Figure 1 CMO Dr. Joshua Landy talks building ‘Instagram for doctors’
Former US Chief Data Scientist DJ Patil: NIH must partner with Google, Amazon, others to drive AI advancements
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.